Stone X Group Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History
Stone X Group Inc.
- $2.06 Trillion
- Q2 2025
Shares
1 transactions
Others Institutions Holding CRBP
# of Institutions
4Shares Held
38.7KCall Options Held
0Put Options Held
0-
Kingsbury Capital Investment Advisors LLC Evanston, IL33.7KShares$379,1250.01% of portfolio
-
Exane Derivatives2.65KShares$29,8120.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.31KShares$26,0100.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About Corbus Pharmaceuticals Holdings, Inc.
- Ticker CRBP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 125,268,000
- Market Cap $1.41B
- Description
- Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...